Changes with age in the structure of fibromodulin in human articular cartilage - PubMed (original) (raw)
Changes with age in the structure of fibromodulin in human articular cartilage
P J Roughley et al. Osteoarthritis Cartilage. 1996 Sep.
Free article
Abstract
An anti-peptide antibody was raised in a rabbit against the carboxy terminal region of the human fibromodulin core protein. The antibody was purified from other components of the resulting antiserum by affinity chromatography using the immobilized peptide, and was used to study the structural heterogeneity of fibromodulin extracted from human articular cartilage of different ages by the use of immunoblotting following sodium dodecyl sulfate polyacrylamide gel electrophoresis analysis of the extracted macromolecules. In the fetus and neonate, fibromodulin was visualized as a diffuse component with a relative molecular weight of 70-110 kDa, whereas in the mature adult a more discrete component of smaller size was apparent with a relative molecular weight of 67 kDa. The size of the fibromodulin from mature adult cartilage could not be altered by pretreatment of the samples with keratanase II or endo-beta-galactosidase before analysis. In contrast, the size of the fibromodulin from younger cartilage could be decreased with both glycosidases, with the endo-beta-galactosidase yielding a smaller product than the keratanase. The size of the product resulting from endo-beta-galactosidase treatment of the fibromodulin from young cartilage was the same as that of the intact fibromodulin from mature adult cartilage. Thus, fibromodulin is present in human articular cartilage at all ages, but the extracted molecules only appear to exist in a proteoglycan form possessing keratan sulfate chains in the juvenile and young adult, and the size of these chains decreases with age. In the mature adult the fibromodulin does not possess either keratan sulfate or non-sulfated polylactosamine chains, though it appears to possess the same number of N-linked oligosaccharides as its counterparts from the younger tissue, but they are not modified further. The majority of the fibromodulin extracted from arthritic cartilage is of the same size as that found in the normal mature adult, although there is evidence for proteolytic processing. The degree of such processing is greater for the fibromodulin obtained from the cartilage of rheumatoid arthritic joints than osteoarthritic joints.
Similar articles
- The structure of the keratan sulphate chains attached to fibromodulin from human articular cartilage.
Lauder RM, Huckerby TN, Nieduszynski IA. Lauder RM, et al. Glycoconj J. 1997 Aug;14(5):651-60. doi: 10.1023/a:1018552913584. Glycoconj J. 1997. PMID: 9298700 - The structure of the keratan sulphate chains attached to fibromodulin isolated from articular cartilage.
Lauder RM, Huckerby TN, Nieduszynski IA. Lauder RM, et al. Eur J Biochem. 1996 Dec 1;242(2):402-9. doi: 10.1111/j.1432-1033.1996.0402r.x. Eur J Biochem. 1996. PMID: 8973659 - Characterization of the macromolecular components of the articular cartilage surface.
Noyori K, Takagi T, Jasin HE. Noyori K, et al. Rheumatol Int. 1998;18(2):71-7. doi: 10.1007/s002960050060. Rheumatol Int. 1998. PMID: 9782536 - Cartilage proteoglycans: structure and potential functions.
Roughley PJ, Lee ER. Roughley PJ, et al. Microsc Res Tech. 1994 Aug 1;28(5):385-97. doi: 10.1002/jemt.1070280505. Microsc Res Tech. 1994. PMID: 7919526 Review. - Electron microscopic studies of cartilage proteoglycans.
Buckwalter JA, Rosenberg LC. Buckwalter JA, et al. Electron Microsc Rev. 1988;1(1):87-112. doi: 10.1016/s0892-0354(98)90007-7. Electron Microsc Rev. 1988. PMID: 3155020 Review.
Cited by
- Hippocampal differential expression underlying the neuroprotective effect of delta-9-tetrahydrocannabinol microdose on old mice.
Shapira G, Israel-Elgali I, Grad M, Avnat E, Rachmany L, Sarne Y, Shomron N. Shapira G, et al. Front Neurosci. 2023 Jul 18;17:1182932. doi: 10.3389/fnins.2023.1182932. eCollection 2023. Front Neurosci. 2023. PMID: 37534036 Free PMC article. - The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican.
Berdiaki A, Giatagana EM, Tzanakakis G, Nikitovic D. Berdiaki A, et al. Cancers (Basel). 2023 Jul 9;15(14):3549. doi: 10.3390/cancers15143549. Cancers (Basel). 2023. PMID: 37509212 Free PMC article. Review. - Lumican in Carcinogenesis-Revisited.
Giatagana EM, Berdiaki A, Tsatsakis A, Tzanakakis GN, Nikitovic D. Giatagana EM, et al. Biomolecules. 2021 Sep 6;11(9):1319. doi: 10.3390/biom11091319. Biomolecules. 2021. PMID: 34572532 Free PMC article. Review. - Small leucine-rich proteoglycans in physiological and biomechanical function of bone.
Hua R, Jiang JX. Hua R, et al. Matrix Biol Plus. 2021 May 6;11:100063. doi: 10.1016/j.mbplus.2021.100063. eCollection 2021 Aug. Matrix Biol Plus. 2021. PMID: 34435181 Free PMC article. Review. - Ex Vivo Equine Cartilage Explant Osteoarthritis Model: A Metabolomics and Proteomics Study.
Anderson JR, Phelan MM, Foddy L, Clegg PD, Peffers MJ. Anderson JR, et al. J Proteome Res. 2020 Sep 4;19(9):3652-3667. doi: 10.1021/acs.jproteome.0c00143. Epub 2020 Aug 6. J Proteome Res. 2020. PMID: 32701294 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical